Home » Stocks » JNJ

Johnson & Johnson (JNJ)

Stock Price: $168.20 USD -0.68 (-0.40%)
Updated May 12, 2021 4:00 PM EDT - Market closed
After-hours: $168.49 +0.29 (0.17%) May 12, 7:14 PM
Market Cap 444.25B
Revenue (ttm) 84.21B
Net Income (ttm) 15.12B
Shares Out 2.63B
EPS (ttm) 5.66
PE Ratio 29.71
Forward PE 17.76
Dividend $4.04
Dividend Yield 2.40%
Trading Day May 12
Last Price $168.20
Previous Close $168.88
Change ($) -0.68
Change (%) -0.40%
Day's Open 168.54
Day's Range 167.95 - 169.80
Day's Volume 6,757,904
52-Week Range 131.91 - 172.57


Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Women who were 30- to 39-years old accounted for the biggest risk group who developed rare blood clots following J&J's Covid vaccine.

2 hours ago - CNBC

Its dividend already pays more than what you'd get from the average stock on the S&P 500.

12 hours ago - The Motley Fool

India reported 4,205 deaths on Wednesday, its worst single-day toll so far as the second wave shows no signs of relenting.

15 hours ago - Forbes

"I do not believe (the J&J vaccine pause) was a setback, I think it really underscored how how seriously we all take safety," Dr. Anthony Fauci told Congress.

1 day ago - CNBC

Get a look at one of the stocks in the most recent Dividend Growth stocks Model Portfolio.

1 day ago - Forbes

The government is having issues with giving away its excess supply.

Other stocks mentioned: AZN, BNTX, MRNA, NVAX, PFE
1 day ago - The Motley Fool

They're masters of pricing, not to mention their supply chains.

Other stocks mentioned: COST
1 day ago - The Motley Fool

Neighboring Denmark has already dropped both shots from its vaccination campaign.

Other stocks mentioned: AZN
2 days ago - Forbes

The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.

Other stocks mentioned: AZN, BBH, BTEC, FBT, IBB, MRNA, PFE ...
5 days ago - Zacks Investment Research

Just 46% of respondents said they were at least somewhat confident in the J&J shot, compared with 69% who said the same for Pfizer and Moderna's vaccines.

5 days ago - CNBC

Oppenheimer health care analyst on whether vaccine makers should lose sleep over patent waivers

YouTube video

Hartaj Singh, Oppenheimer & Co, on Covid vaccine makers under pressure as the patent waiver conversation continues. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Pete Najarian, Jeff Mil...

Other stocks mentioned: AZN, BNTX, MRNA, NVAX, PFE
6 days ago - CNBC Television

Pfizer fell Thursday by as much as 5% from Wednesday's close while Moderna dipped by almost 12% before both stocks recovered most of those losses.

Other stocks mentioned: BNTX, MRNA, NVAX, PFE
6 days ago - CNBC

After a brief selloff in Q1 2021, growth stocks are once again in focus. Investors can take advantage of this by investing in growth companies trading at low valuations.

Other stocks mentioned: A, DELL, GS, TGT
6 days ago - InvestorPlace

FATE reports a wider Q1 loss on increased R&D expenses.

Other stocks mentioned: BMY, FATE, GILD
6 days ago - Zacks Investment Research

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?

6 days ago - Zacks Investment Research

While it's easy to get carried away with the speculation, investors should consider these safe stocks to hand down to their progeny. The post 7 Safe Stocks You Can Leave to Your Children appeared first ...

Other stocks mentioned: ADM, CSV, DIS, MCD, MSFT, PG
6 days ago - InvestorPlace

U.S. backs COVID-19 vaccine patent waiver

YouTube video

Yahoo Finance's Brian Sozzi, Myles Udland, Julie Hyman, and Anjalee Khemlani discuss what the vaccine patent waiver means for Moderna's business.

Other stocks mentioned: BNTX, MRNA, NVAX, PFE
6 days ago - Yahoo Finance

Here's why you haven't missed the boat on this blue chip.

6 days ago - The Motley Fool

If enacted, such a move would hit the smaller vaccine makers particularly hard.

Other stocks mentioned: BNTX, MRNA, PFE
6 days ago - The Motley Fool

They're built for the long run.

Other stocks mentioned: LOW, WMT
1 week ago - The Motley Fool

Johnson & Johnson (JNJ) closed at $167.77 in the latest trading session, marking a +1.55% move from the prior day.

1 week ago - Zacks Investment Research

Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.

Other stocks mentioned: AZN, BBH, BTEC, FBT, IBB, IBRX, NVAX ...
1 week ago - Zacks Investment Research

So, which blue-chip stocks with strong earnings should you keep an eye on? Consider these eight some of the best ones out there.

Other stocks mentioned: CAT, FB, GOOG, GOOGL, LMT, MMM, MSFT
1 week ago - InvestorPlace

The number of Americans who prefer J&J's Covid-19 vaccine declined after the U.S. paused its use to investigate safety, but 17% still say it's their top choice.

1 week ago - CNBC

Hint: It wasn't the company's COVID-19 vaccine.

1 week ago - The Motley Fool

The country's health agency said the risks of the vaccine outweigh the benefits, despite the European Medicines Agency saying the opposite.

1 week ago - Forbes

3 Big Drugmaker Stocks to Watch Out For Amid Pandemic Woes

Other stocks mentioned: ABBV, AZN, LLY, MRK, NVS, PFE
1 week ago - Zacks Investment Research

Rapid innovation is boosting the robotic surgery space, putting the spotlight on Johnson & Johnson (JNJ), Stryker (SYK), Boston Scientific (BSX), Intuitive Surgical (ISRG) and Asensus Surgical (ASXC).

Other stocks mentioned: ASXC, BSX, ISRG, SYK
1 week ago - Zacks Investment Research

These two blue-chip pharmaceuticals pay great dividends.

Other stocks mentioned: MRK
1 week ago - The Motley Fool

These proven stocks look primed to grow your money manifold in the coming years.

Other stocks mentioned: MA, WCN
1 week ago - The Motley Fool

Emergent BioSolutions Inc (NYSE: EBS) has manufactured over 115 million doses of drug substance used in the Johnson & Johnson (NYSE: JNJ) COVID-19 vaccine, 60 million doses of which are in vials and rea...

Other stocks mentioned: EBS
1 week ago - Benzinga

Investors have been embracing momentum for a while. Is that trend about to reverse?

1 week ago - The Motley Fool

High-quality pharmaceutical stocks comes with steady business, low valuations and solid dividend. Let's look at a handful of them now.

Other stocks mentioned: ABBV, AMGN, BMY, MRNA, PFE, SFY
1 week ago - InvestorPlace

Discussing the biggest news in the markets.

Other stocks mentioned: CMG, ISRG, MKTX, NFLX, PATH, RBLX, SAM
2 weeks ago - The Motley Fool

Whether you're looking for reliable and growing dividends, or you seek high yields, you may find something you like with these dividend ETFs. The post 7 Great ETFs to Buy for Dividend-Hungry Investors a...

Other stocks mentioned: DVYE, JPM, SDIV, VIG, VPU, VYM
2 weeks ago - InvestorPlace

BeiGene Ltd (NASDAQ: BGNE) announced positive results from a planned interim analysis of the Phase 3 ALPINE trial comparing Brukinsa (zanubrutinib) against Johnson & Johnson's (NYSE: JNJ) Imbruvica (ibr...

Other stocks mentioned: BGNE
2 weeks ago - Benzinga

Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that dominate...

Other stocks mentioned: ABBV, FHLC, GILD, IYH, MRK, PFE, TMO ...
2 weeks ago - Zacks Investment Research

There are 11 low-volatility ETFs with assets more than $1 billion. Here are 10 safe stocks from the top five of those ETFs.

Other stocks mentioned: BABA, EXPD, MCD, MSFT, NGG, TSM, UL ...
2 weeks ago - InvestorPlace

From dividends to growth to overall stability, these stocks will give your portfolio a great mix.

Other stocks mentioned: ABT, ISRG
2 weeks ago - The Motley Fool

So, which pharmaceutical stocks should be on your radar, if dividends are a top priority? Consider these seven compelling opportunities.

Other stocks mentioned: ABBV, BMY, GILD, GSK, NVS, MRK
2 weeks ago - InvestorPlace

Other stocks mentioned: ABBV, AMGN, AZN, BMY, GILD, MRK
2 weeks ago - GuruFocus

Increasing dividend payments is just par for the course for these companies.

Other stocks mentioned: COST, SO
2 weeks ago - The Motley Fool

Its vaccine might not have panned out as expected, but Merck has more in the works.

Other stocks mentioned: ABBV, MRK, PFE
2 weeks ago - The Motley Fool

There are other factors to consider.

2 weeks ago - The Motley Fool

73% of Americans are not willing to get the Johnson & Johnson vaccine: Report

YouTube video

#J&Jvaccine Dr. Manish Garg, Emergency Medicine Physician & Co-Founder of World Academic Council of Emergency Medicine, joins Yahoo Finance's Sibile Marcellus and Alexis Christoforous to discuss the lat...

2 weeks ago - Yahoo Finance

Roughly 57% of investor votes cast backed healthcare company Johnson & Johnson's executive pay for 2020, a low level of support for a proposal most shareholders usually rubberstamp.

2 weeks ago - Reuters

The more defensive sectors of the economy are usually some of the best places to find stocks with growing dividends. Companies that can navigate difficult economic conditions generally have consistent g...

Other stocks mentioned: PG, SO
2 weeks ago - GuruFocus

Johnson & Johnson (NYSE:JNJ) has been in the news for a number of reasons lately.

2 weeks ago - GuruFocus

Experts say the pause should boost public confidence in vaccines.

2 weeks ago - Forbes

About JNJ

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the S... [Read more...]

Drug Manufacturers-General
Alex Gorsky
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

In 2020, JNJ's revenue was $82.58 billion, an increase of 0.64% compared to the previous year's $82.06 billion. Earnings were $14.71 billion, a decrease of -2.68%.

Financial Statements

Analyst Forecasts

According to 19 analysts, the average rating for JNJ stock is "Buy." The 12-month stock price forecast is 186.80, which is an increase of 11.06% from the latest price.

Price Target
(11.06% upside)
Analyst Consensus: Buy